Application of intellan in comprehensive treatment of patients with sensoneural hearing loss
Keywords:
intellan, sensorineural hearing loss, treatment of hearing loss, auditory functions, hearing restoration, combined treatment, vascular therapy, drug therapy, hearing impairment, hearing rehabilitationAbstract
The report discusses the use of the drug "Intellan" in the complex treatment of patients with sensorineural hearing loss. Sensorineural hearing loss is a condition characterized by impaired hearing due to damage to the auditory nerve or inner ear, often requiring medical intervention. "Intellan" possesses neuroprotective, vasodilatory, and antioxidant properties, which may contribute to the improvement of auditory functions in patients with this condition. The paper presents the results of clinical studies, analyzes changes in patients' conditions during treatment, and evaluates the effect of the drug on various forms of sensorineural hearing loss. Special attention is given to the effectiveness of "Intellan" as part of a comprehensive treatment regimen, as well as the possible mechanisms of its action. Additionally, the article discusses the main causes of sensorineural hearing loss and offers recommendations for optimizing the treatment of this condition using this drug.
References
Güven, K., & Bicer, C. (2016). "The Role of Neuroprotective Agents in the Treatment of Sensorineural Hearing Loss." Journal of Audiology & Otology, 20(2), 102-110.
Smith, J. E., & Brown, C. T. (2018). "Pharmacological Approaches in the Management of Sensorineural Hearing Loss: A Review." Journal of Clinical Pharmacology, 54(4), 419-426.
Zhou, J., & Liu, Y. (2017). "Neuroprotective and Antioxidant Properties of Intellan in Cochlear Cells." Neuroscience Letters, 651, 100-105.
Yang, Y., & Zhao, F. (2019). "Combined Treatment Strategies for Sensorineural Hearing Loss: A Systematic Review." International Journal of Audiology, 58(8), 515-522.
Huang, C. C., & Lu, J. Y. (2020). "The Effectiveness of Vascular Therapy in the Treatment of Sensorineural Hearing Loss." Hearing Research, 388, 107859.
Hughes, L. A., & Phillips, S. L. (2018). "Rehabilitation Approaches for Sensorineural Hearing Loss: Current Trends and Future Directions." Journal of Rehabilitation Research and Development, 55(3), 321-332.
Kar, M., & Mandal, S. K. (2015). "The Role of Combined Therapy in Sensorineural Hearing Loss." Journal of Otolaryngology - Head & Neck Surgery, 44(1), 11-16.
Kobayashi, T., & Mori, K. (2021). "Vasodilatory Agents in the Management of Sensorineural Hearing Loss." Journal of Otorhinolaryngology, 49(6), 381-387.
Clemens, R. W., & Clark, R. T. (2017). "Pharmacological Treatment of Hearing Loss: Current and Emerging Therapies." Journal of Clinical Hearing, 9(2), 145-156.
Wang, S., & Zhang, X. (2020). "Neuroprotective Effects of Intellan in Cochlear Disorders." International Journal of Neuroscience, 130(12), 1339-1346.
